[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2014-2018 World Tuberculosis Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-- US, Europe (France, Germany, Italy, Spain, UK), Japan

November 2014 | 208 pages | ID: TF157EAF0C6EN
Venture Planning Group

US$ 3,480.00 US$ 4,350.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Tuberculosis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.Contains 208 pages and 15 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests
  • Microscopic Characteristics
  • Cultural Characteristics
  • Detection of Antibodies
  • Skin Tests
  • MDRTB
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
  • Polymerase Chain Reaction
    • Robotics
    • Temperature Cyclers
    • PCR Variations
  • Immuno-PCR
  • QC-PCR
  • DAP-PCR
  • Ligase Chain Reaction
  • Branched DNA
  • Q-Beta Replicase
  • Nucleic-Acid Sequence-Based
  • Strand Displacement Activation
  • Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
  • Overview
  • ELISA
  • Dot Immunobinding Assays
  • Capillary Immunoassays
  • Particle-Membrane Capture Immunoassays
  • Enzyme Amplification
    c. Fluorescent Immunoassays
  • Fluorescence Polarization
  • Time-Resolved Pulse Fluorescence
    d. Luminescence
  • Chemiluminescence
  • Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Differential Light Scattering
  5. Microcomputers and Automation
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS
  • Abbott
  • Affymetrix
  • Applera
  • Beckman Coulter
  • Becton Dickinson
  • Binding Site
  • Biomerica
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotrol
  • Biosite
  • Biotest
  • Caliper Technologies
  • Cepheid
  • Chemicon
  • Daiichi
  • DiaSorin
  • Diagast
  • Diamedix
  • Digene
  • Eiken
  • Enzo Biochem
  • Fujirebio
  • GenBio
  • Gene-Tec
  • Hemagen
  • Immunetics
  • Innogenetics
  • Inverness
  • J&J
  • Meridian
  • Nanogen
  • Nissui
  • Olympus
  • Provalis
  • Roche
  • Saliva Diagnostic
  • SeraCare
  • Siemens
  • Third Wave Technologies
  • Thermo Fisher
  • Tosho
  • Trinity Biotech
  • Tropix
  • Wampole Labs
  • Zenith
  • Zeus

LIST OF TABLES

Major Companies Developing or Marketing Tuberculosis Tests
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Germany Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Italy Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Japan Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Spain Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.K. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Tuberculosis Testing Market Diagnostics Sales by Major Supplier


More Publications